|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61P 11/00 | |
| A61K 31/4035 | |||
| A61K 31/443 | |||
| A61K 31/47 | |||
| A61K 45/06 |
| (11) | Patento numeris | 3142748 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15727144.6 |
| Europos patento paraiškos padavimo data | 2015-05-14 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-22 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-09-11 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2015/030764 |
| Data | 2015-05-14 |
| (87) | Numeris | WO 2015/175773 |
| Data | 2015-11-19 |
| (30) | Numeris | Data | Šalis |
| 201461993467 P | 2014-05-15 | US |
| (72) |
SCHAFER, Peter, US
KORISH, Shimon, US
|
| (73) |
Celgene Corporation,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | USE OF PDE4 INHIBITORS AND COMBINATIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS |
| USE OF PDE4 INHIBITORS AND COMBINATIONS THEREOF FOR THE TREATMENT OF CYSTIC FIBROSIS |